Actively Acquired Immunity
DBCAT004055Pharmacologic class
A DrugBank category of 94 drugs. 93 of them are approved.
- Drugs
- Adenovirus type 7 vaccine live
- Anthrax vaccine
- Bacillus calmette-guerin substrain tice live antigen
- Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)
- Bordetella pertussis fimbriae 2/3 antigen
- Bordetella pertussis pertactin antigen (formaldehyde inactivated)
- Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
- Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)
- Clostridium tetani toxoid antigen (formaldehyde inactivated)
- Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
- Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
- Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
- Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
- Hepatitis A Vaccine
- Hepatitis B Vaccine (Recombinant)
- Human adenovirus e serotype 4 strain cl-68578 antigen
- Human papillomavirus type 11 L1 capsid protein antigen
- Human papillomavirus type 16 L1 capsid protein antigen
- Human papillomavirus type 18 L1 capsid protein antigen
- Human papillomavirus type 6 L1 capsid protein antigen
- Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
- Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
- Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
- Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
- Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
What you can answer from here — as of September 06, 2018
Which targets do Actively Acquired Immunity share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account